2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

[HTML][HTML] Physical activity and exercise: Strategies to manage frailty

J Angulo, M El Assar, A Álvarez-Bustos… - Redox biology, 2020 - Elsevier
Frailty, a consequence of the interaction of the aging process and certain chronic diseases,
compromises functional outcomes in the elderly and substantially increases their risk for …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

A Velleca, MA Shullo, K Dhital, E Azeka… - The Journal of Heart …, 2023 - jhltonline.org
Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial

JH Butt, P Dewan, B Merkely, J Belohlávek… - Annals of internal …, 2022 - acpjournals.org
Background: Frailty may modify the risk− benefit profile of certain treatments, and frail
patients may have reduced tolerance to treatments. Objective: To investigate the efficacy of …

Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial

JH Butt, PS Jhund, J Belohlávek, RA De Boer… - Circulation, 2022 - Am Heart Assoc
Background: Frailty is increasing in prevalence. Because patients with frailty are often
perceived to have a less favorable risk/benefit profile, they may be less likely to receive new …

Short physical performance battery and all-cause mortality: systematic review and meta-analysis

R Pavasini, J Guralnik, JC Brown, M di Bari, M Cesari… - BMC medicine, 2016 - Springer
Abstract Background The Short Physical Performance Battery (SPPB) is a well-established
tool to assess lower extremity physical performance status. Its predictive ability for all-cause …

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update

MR Mehra, CE Canter, MM Hannan… - The Journal of Heart …, 2016 - jhltonline.org
In 2005, the International Society for Heart and Lung Transplantation (ISHLT) Board of
Directors commissioned the development of the first International Listing Criteria for Heart …

Frailty assessment in the cardiovascular care of older adults

J Afilalo, KP Alexander, MJ Mack, MS Maurer… - Journal of the American …, 2014 - jacc.org
Due to the aging and increasingly complex nature of our patients, frailty has become a high-
priority theme in cardiovascular medicine. Despite the recognition of frailty as a pivotal …

Cachexia, muscle wasting, and frailty in cardiovascular disease

A Bielecka‐Dabrowa, N Ebner… - European journal of …, 2020 - Wiley Online Library
The last several years have seen increasing interest in understanding cachexia, muscle
wasting, and physical frailty across the broad spectrum of patients with cardiovascular …